Gurus' Views & Strategies

The Week Ahead: The Good, the Bad, or the Ugly?
Specialty: STRATEGIES
Keyword Image
Published: 2/1/2013
By Tom Aspray, Senior Editor, MoneyShow.com
Tickers mentioned: SPY, DIA, QQQ, IWM, GLD

January was clearly a bullish month for stocks, and MoneyShow's Tom Aspray digs into previous years with hot starts to see what investors might expect in 2013. However, although this rally may have some room left, there may be more important considerations if you already have substantial gains.

After a record-breaking week, investors were closely watching Friday’s monthly jobs report to see if it would dampen the recent enthusiasm regarding the stock market. Instead, the report showed that job growth in 2012 was better than most thought, and the Dow Industrials and S&P 500 made new highs for the week and closed strong.

Clearly, stocks have gotten the public’s attention. Even the local TV channels have devoted more time to discussing the stock market. Many have focused on the January Barometer—historically when stocks are higher in January, it is a positive sign for the whole year.

A recent Wall Street Journal article reported that since 1929, a higher January close in the S&P 500 has resulted in an average 13% gain. This is in contrast to the average 3.6% loss in those years when stocks are lower in January.

Of course, within these averages there has been a wide range in performance, and we have seen the full gamut in the last 20 years. Let’s take a look at the good, the bad, and the truly ugly years, so we are better prepared for 2013.

chart
Click to Enlarge

The performance in 2013 was the best since 1997, and we can all hope that this year turns out as well. In January 1997, the S&P 500 was up 6.1%, but then bottomed out on February 18, as it dropped 10.4% from the January close. This took the S&P 500 to 733.5, which was slightly below the 1996 close of 740.7.

The rebound from the April lows was very impressive, with the S&P finishing up 31% for the year. There was plenty of volatility during the year, including a 13.6% plunge in October 1997.

By comparison, 1994 could be considered a bad year given the averages. In January 1994, the S&P 500 gained 3.3% and peaked on January 31 at 482.8. Given the scaling, the drop into the lows on April 4 looks much worse than 6.5%.

That turned out to be the low for the year. Prices came close to the January high in August, when the S&P 500 reached 477.6. For the year, the S&P 500 was down 1.8%.

chart
Click to Enlarge

Still, this does not look that bad compared to 2001, when the S&P closed up 3.5% in January. The high for the year came at the end of January, as it dropped 18.7% to a low in the latter part of March.

The S&P rallied over 17% from this low and hit the 78.6% Fibonacci retracement resistance in May before the sellers again took over. At the year’s lows in September, the S&P 500 was down 31.3% from the January close. The S&P 500 was able to rally for the rest of the year, but still closed down 13.1% .

So what will 2013 be like?

NEXT: What to Watch

Page 1 | Page 2 | Page 3 | Page 4 | Next Page

TRADESHOW LOCATIONS

Show Logo
San Francisco
 • August 15 – 17, 2013
Free eLetters

Receive all-new market analysis and commentary, timely recommendations, exclusive videos, and much more from hundreds of top experts. Subscribe today!

INVESTING ELETTERS

   More Details

Daily Investing Alert

Weekly Investing eLetter

Hot Off The Tape Weekly Video eLetter

TRADING ELETTERS

   More Details

Daily Trading Alert

Trading Lessons

Trader Talk Podcast

Most Popular

Keyword Image The Week Ahead: Will 2013 Be Another Double-Digit Year?
A test of all-time stock highs looks highly likely next year, but the market's reaction to fiscal...
Add Some Energy to Your Holdings
A Test for Gold Investors  Video Logo
Large-Cap Winners & Losers
Sponsored Links

CEMIG

Cemig (NYSE:CIG) is one of Brazil's largest and most profitable electricity concession holders.…

Aflac Incorporated

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash…

InVivo Therapeutics Corporation

InVivo Therapeutics Corporation is a Cambridge, Massachusetts-based medical device company founded…

Aflac Incorporated

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash…